Journal profile · Allergy
Current Allergy & Clinical Immunology
ISSN 1609-3607 · Allergy Society of South Africa · ALLSA · Quarterly · Founded 1987
Current Allergy & Clinical Immunology: CAS Zone 4 · Medicine (2025 upgraded edition); subscription journal; review over 12 weeks (community reports); community-reported acceptance: easy; 0 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Allergy & Clinical Immunology is published by Allergy Society of South Africa and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research and Allergic Rhinitis and Sensitization, together about 48.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Current Allergy and Clinical Immunology is the official journal of the Allergy Society of South Africa and is produced as a service to understanding and communication in the field of allergy.
Source: LetPub
Research area (LetPub): Allergy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine17.6%
- Food Allergy and Anaphylaxis ResearchMedicine17.1%
- Allergic Rhinitis and SensitizationMedicine14.1%
- Drug-Induced Adverse ReactionsMedicine8.6%
- Contact Dermatitis and AllergiesMedicine6.7%
- Occupational exposure and asthmaMedicine6.5%
- Dermatology and Skin DiseasesMedicine4.2%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Immunology and Allergy | Q4 | 223/234 | 4th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.17LetPub ·
- SNIP 2026-06
- 0.19LetPub ·
- h-index
- 8LetPub ·
- h-index
- 9OpenAlex ·
- i10-index
- 9OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 16LetPub ·
Articles by year OpenAlex count · 317 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2025 | 0 | 0 | 8 |
| 2024 | 0 | 0 | 13 |
| 2023 | 0 | 0 | 15 |
| 2022 | 0 | 0 | 14 |
| 2021 | 2 | 0 | 37 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Allergy Society of South Africa
- Country or region
- ALLSA
- Frequency
- Quarterly
- Founded
- 1987
- ISSN
- 1609-3607
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Allergy & Clinical Immunology
What CAS zone is Current Allergy & Clinical Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Allergy & Clinical Immunology is in Zone 4 of Medicine, and in Zone 4 of the minor category Allergy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Current Allergy & Clinical Immunology?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Allergy & Clinical Immunology?
According to LetPub and DOAJ records, Current Allergy & Clinical Immunology is indexed in ESCI and Scopus.
Is Current Allergy & Clinical Immunology open access, and what is the APC?
Current Allergy & Clinical Immunology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .